Company Update

As you all know the spread of the COVID-19 is now dominating the agenda all over the world. Elekta is managing the situation closely and many of our colleagues are together with you right now carrying out important and vital work, under challenging conditions.

We are fully committed to you, as our partners and customers, and to the patients you treat. While taking every step necessary to keep our colleagues safe and to further prevent spreading, we will do our utmost to service you, with regards to international guidelines and local regulations. Our teams will work together with you to overcome any potential obstacle due to restrictions, and find the best possible solutions available.

You can find updated guidance relating to the use of Elekta products and solutions on the Elekta Care Community portal.

Elekta Care Community

Company Update



In light of recent developments around coronavirus (COVID-19) in Europe, ESTRO has made the decision to postpone ESTRO 2020 and the World Congress of Brachytherapy 2020. At Elekta, we support this decision and are also cancelling all of our related events in April in Vienna.

We believe this is the right decision given the current circumstances and recommendations from the World Health Organization. The team at Elekta fully appreciate and welcome this decision as your health and safety, along with our customers and own staff is our number one priority.

We are also keeping those directly affected by COVID-19 in our thoughts.

Learn more


Elekta Unity

Three reasons why Elekta Unity is so useful

Since Elekta Unity has gone clinical, we have received excellent customer feedback. Dr Alison Tree, Consultant Clinical Oncologist at The Royal Marsden and Team Leader in Uro-oncology Clinical Trials at the ICR, explains three key attributes that Elekta Unity fulfills:

  • Precision
  • Ability to monitor in real time
  • Adaptive treatment plan

Find out more in this video about how important Elekta Unity is to clinicians and patients.

Elekta Unity

Versa HD

Stereotaxy Made Easy

Value-based healthcare could lead to an increase in hypofractionation. We have the solutions to make SRS and SBRT treatments accessible for all.

With Versa HD HDRS — and our advanced imaging and QA solutions — you can perform:

  • Intracranial SRS in 15 minutes or less
  • Lung SBRT treatment in less than 2 minutes
  • Prostate SBRT treatment in 90 seconds

Learn more about Versa HD

Versa HD

Elekta Assurance

New levels of automation and integration for advanced QA

Quality assurance is a vital part of any radiotherapy service. As treatment technology and complexity have developed, so has the burden of QA — in terms of both time and cost.

How can Elekta Assurance help?

  • Flexible and scalable solutions can shape to fit every customer and offer any QA at any time, for any clinic
  • Centralized and accessible data can effortlessly maintain compliance, reducing time spent on administration
  • Automated workflows can reduce test time up to 90% — so that experts can focus on results rather than tests
  • Innovative real-time and end-to-end QA can bring enhanced confidence and efficiency to any treatment

Explore Elekta Assurance

Elekta Assurance

Leksell Gamma Knife® Icon™

A dedicated intracranial system

Dr. Matthew Foote, radiation oncologist at Princess Alexandra Hospital, Australia, and Dr. Joseph Bovi, radiation oncologist at Froedtert & The Medical College of Wisconsin, describe how a dedicated intracranial system benefits their clinics and the care they give to patients.

Leksell Gamma Knife® Icon™

FOCUS | Elekta’s Online Magazine

News 1

April 6, 2020

Clarity Autoscan improves radiotherapy delivery accuracy for prostate cancer

Due largely to China's aging population, prostate cancer has emerged as the sixth most common cancer in the country1, driving a surge in prostate cancer patients at the nation's medical centers. To enable more accurate radiotherapy treatments of individuals with...

News 1

March 27, 2020

The case for MR-to-MR deformable image registration with Elekta Unity MR-Linac

The superior soft tissue visualization of MR-guided radiotherapy offers the potential to greatly increase the accuracy of each patient's treatment fraction. However, this requires the targets and organs-at-risk (OARs) to be defined on the daily MRI scan. This task of...

News 1

March 18, 2020

Standardizing cervical cancer brachytherapy in India

Cases of cervical cancer can be found in all parts of the world, but the incidence of the disease is much greater in LMIC's (low and middle-income countries, e.g., India, Nepal, African nations) than in Western countries. Of GLOBOCAN's 2018...


More stories